Similarly, the combination Ca/N treatment induced upregulation of both MHC Class I and II (HLA-ABC, HLA-DR), as well as PD-L1 expression on tumor cells treated with combination Ca/N relative to the controls (Figure 5E). The gene discussed is CD274; the disease is neoplasm.